FindTrial
Sign In

NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers

Relationship of Edoxaban Plamsa Concentration and Blood Coagulation in Healthy Volunteers Using Standard Laboratory Tests and Viscoelastic Analysis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03666650
Acronym
EdoRot
Enrollment
15
Registered
2018-09-12
Start date
2018-11-26
Completion date
2019-01-08
Last updated
2019-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Coagulation Disorder

Brief summary

Relationship of edoxaban plasma concentration and blood coagulation in healthy volunteers using standard laboratory tests and viscoelastic analysis

Interventions

DRUGEdoxaban 60 MG

Viscoelastic analysis and standard laboratory tests after edoxaban ingestion

Sponsors

Helsinki University Central Hospital
CollaboratorOTHER
Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

healthy

Exclusion criteria

intolerance of the study drug history of bleeding disorder or similar

Design outcomes

Primary

MeasureTime frameDescription
correlation of edoxaban peak plasma concentrations and viscoelastic analysis1 dayviscoelastic test values and blood coagulation laboratory parameters

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026